Back to Locations

University Hospitals of Cleveland

11100 Euclid Avenue - Cleveland, OH 44106

For information about clinical trials being conducted in Cleveland, OH, please contact Courtney Maguire at 216-844-5470.


Tamila Kindwall-Keller, D.O. (Principal Investigator)

Trials at this Location:


Disease: Breast
Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic - BRE-126
Status: Open to Accrual at Limited Institutions Only - Open to Accrual 06-26-2009; 21 of 44 accrued.
More Details
Disease: Breast
PARP Inhibition after Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer or ER/PR +, HER2 negative with known BRCA1/2 Mutations - BRE09-146
Status: Opened 2/22/2010; 7 of 135 Accrued
More Details
Disease: Breast
Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative - DoD COE-03 (BRE-126)
Status: Open to Accrual at Limited Institutions Only - Open to Accrual 06-26-2009; 21 of 44 accrued.
More Details
Disease: Multiple Myeloma
A Phase I/II trial of Bendamustine in Combination with Bortezomib and Pegylated Liposomal Doxorubicin (Doxil) in Patients with Relapsed or Refractory Multiple Myeloma - MM08-141
Status: Open to Accrual 03/05/2010
More Details